Alaunos Therapeutics (TCRT) Change in Receivables (2011 - 2026)
Alaunos Therapeutics (TCRT) reported Change in Receivables of -$3000.0 for Q1 2026, little changed on a YoY basis from -$3000.0 in Q1 2025, and down 200.0% quarter-over-quarter from $3000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Change in Receivables (2011 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Change in Receivables for 16 years, with the latest figure at -$3000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables changed 0.0% year-over-year to -$3000.0; the trailing twelve-month figure through Mar 2026 stood at -$2000.0 (down 300.0% YoY), and the FY2025 full-year result was -$2000.0, down 150.0% from the prior year.
- Change in Receivables for Q1 2026 stood at -$3000.0, down from $3000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.9 million in Q3 2022, with the low at -$2.9 million in Q4 2022.
- Historically, Change in Receivables has averaged -$79357.1 across 5 years, with a median of -$2500.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Receivables sank 626.75% — and 2024, when it soared 400.0%.
- Alaunos Therapeutics' Change in Receivables stood at -$2.9 million in 2022, then soared by 100.03% to $1000.0 in 2023, then soared by 400.0% to $5000.0 in 2024, then sank by 40.0% to $3000.0 in 2025, then slumped by 200.0% to -$3000.0 in 2026.
- The last three Change in Receivables figures came in at -$3000.0 (Q1 2026), $3000.0 (Q4 2025), and -$2000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |